AVALON GLOBOCARE CORP (ALBT)
US05344R2031 - Common Stock
Taking everything into account, ALBT scores 0 out of 10 in our fundamental rating. ALBT was compared to 68 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of ALBT have multiple concerns. ALBT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ALBT has reported negative net income.
In the past year ALBT has reported a negative cash flow from operations.
In the past 5 years ALBT always reported negative net income.
ALBT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ALBT has a worse Return On Assets (-74.53%) than 94.03% of its industry peers.
Looking at the Return On Equity, with a value of -329.29%, ALBT is doing worse than 83.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -74.53% | ||
| ROE | -329.29% | ||
| ROIC | N/A |
ROA(3y)-76.78%
ROA(5y)-104.98%
ROE(3y)-209.58%
ROE(5y)-268.15%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 16.97%, ALBT perfoms like the industry average, outperforming 40.30% of the companies in the same industry.
ALBT's Gross Margin has declined in the last couple of years.
ALBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.44%
GM growth 5Y-5.37%
2. Health
2.1 Basic Checks
ALBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBT has less shares outstanding
The number of shares outstanding for ALBT has been reduced compared to 5 years ago.
ALBT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -7.03, we must say that ALBT is in the distress zone and has some risk of bankruptcy.
ALBT's Altman-Z score of -7.03 is on the low side compared to the rest of the industry. ALBT is outperformed by 92.54% of its industry peers.
ALBT has a Debt/Equity ratio of 1.85. This is a high value indicating a heavy dependency on external financing.
ALBT has a Debt to Equity ratio of 1.85. This is in the lower half of the industry: ALBT underperforms 76.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.85 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.03 |
ROIC/WACCN/A
WACC10.31%
2.3 Liquidity
ALBT has a Current Ratio of 0.08. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.08, ALBT is doing worse than 92.54% of the companies in the same industry.
ALBT has a Quick Ratio of 0.08. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.08, ALBT is not doing good in the industry: 92.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.08 | ||
| Quick Ratio | 0.08 |
3. Growth
3.1 Past
ALBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1234.40%.
The Revenue has been growing slightly by 5.19% in the past year.
Measured over the past years, ALBT shows a decrease in Revenue. The Revenue has been decreasing by -4.25% on average per year.
EPS 1Y (TTM)-1234.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-996.27%
Revenue 1Y (TTM)5.19%
Revenue growth 3Y-3.1%
Revenue growth 5Y-4.25%
Sales Q2Q%5.77%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALBT. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ALBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AVALON GLOBOCARE CORP
NASDAQ:ALBT (11/21/2024, 7:06:36 PM)
2.65
-0.13 (-4.68%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.84M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -74.53% | ||
| ROE | -329.29% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.97% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.85 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.08 | ||
| Quick Ratio | 0.08 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1234.4%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.19%
Revenue growth 3Y-3.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y